A fecal lactoferrin test looks for a single protein in a stool sample and uses it to answer one practical question: is there active inflammation inside your intestine right now? Lactoferrin is released by white blood cells that migrate into the gut wall when it is irritated or damaged, so finding a lot of it in stool points to the bowel itself rather than to inflammation somewhere else in the body. Doctors order the test when symptoms such as chronic diarrhea, cramping, or blood could come either from an inflammatory disease or from a sensitive but structurally normal gut. In this article you will learn what the test measures, how to read a high or normal result, how it compares with calprotectin and blood CRP, which everyday factors distort it, and what usually happens next.
What a fecal lactoferrin test measures
Lactoferrin is an iron-binding protein. It is stored inside the granules of neutrophils, the fast-acting white blood cells that arrive first at any site of infection or tissue injury. Neutrophils also carry it in tears, saliva, and breast milk, where it helps starve bacteria of the iron they need to multiply. In the gut, though, its presence carries a different message.
The intestinal lining is normally sealed tightly enough that white blood cells stay in the tissue and do not spill into the bowel contents. When the lining becomes inflamed, neutrophils cross into the intestinal space in large numbers, break apart, and release their contents. Lactoferrin survives digestion reasonably well and remains stable in stool for several days at room temperature, which is exactly what makes it usable as a laboratory marker.
So a fecal lactoferrin test does not diagnose a disease. It quantifies neutrophil traffic into the bowel. That is a narrower but far more useful piece of information than a general inflammation score, because it localizes the problem.
How the sample is collected and analyzed
You collect a small stool sample at home in the container the laboratory provides, usually without any dietary preparation. Most laboratories use an immunoassay, a method in which antibodies bind specifically to human lactoferrin and produce a signal proportional to how much is present. Some run a rapid qualitative version that simply reports positive or negative; others report a number in micrograms per gram of stool. Samples are refrigerated and returned promptly, because delays and heat degrade the protein and can pull a result artificially low.
Because collection habits vary and stool is not uniform, the same principles apply here as with any stool study. If you have ever wondered why two samples from the same week disagree, the answer usually lies in collection timing and in how each laboratory sets its reference range.
Why lactoferrin in stool points to the intestine
Blood-based inflammation markers rise for many reasons. A chest infection, a flare of arthritis, an injury, or recent surgery will all push C-reactive protein upward without telling you anything about the bowel. A fecal lactoferrin test avoids that ambiguity because the protein has to physically reach the intestinal contents to be detected there.
This matters most in the situation clinicians face constantly: a patient with months of diarrhea and abdominal pain who may have inflammatory bowel disease or may have a functional disorder. Both groups feel unwell. Only one group has damaged tissue. A stool marker that reflects neutrophil migration separates them far better than symptoms alone.
The same reasoning explains why microscopy for fecal leukocytes in a stool sample was used for decades before protein assays existed. Counting white blood cells under a microscope was subjective and required a very fresh specimen; measuring the protein they leave behind is reproducible and tolerates transport.
What lactoferrin does not tell you
The test cannot say where along the bowel the inflammation sits, what is causing it, or how severe the tissue damage is in any precise way. It cannot distinguish an infection from an autoimmune process. It also says nothing about digestion or absorption, which is why a separate pancreatic enzyme marker is used when malabsorption is the concern.
How to read your fecal lactoferrin test result
Reference ranges differ between assays, so always read the cutoff printed on your own report rather than one you find online. Many laboratories treat results under roughly 7 micrograms per gram as negative, with a borderline zone just above it and a clearly elevated range beyond. Some report only positive or negative. Interpretation always combines the number with your symptoms, your history, and any other tests run at the same time.
| Result pattern | What it usually suggests | Typical next step |
|---|---|---|
| Negative or low | Active inflammatory bowel disease is much less likely; a functional cause fits the picture | Symptom-based management, reassessment if symptoms change |
| Borderline | Mild or resolving inflammation, or a sampling effect | Repeat the sample in two to four weeks |
| Clearly elevated | Active inflammation somewhere in the bowel | Blood tests, stool infection panel, referral for endoscopy |
| Elevated during known IBD remission | Inflammation may be returning before symptoms do | Review of treatment, closer follow-up |
A low result carries real weight. In someone with typical symptoms of irritable bowel syndrome and no alarm features, a negative stool inflammation marker substantially reduces the chance that an inflammatory disease is being missed and often spares an invasive investigation. That is the test working as intended: not proving a diagnosis, but safely closing off a dangerous one.
Why one number is rarely enough
Inflammation fluctuates. A single sample captures one day. If your result sits near the cutoff and your symptoms persist, a repeat sample is more informative than any amount of reinterpretation of the first one. Clinicians also look at the trend across several results, which is where the marker becomes genuinely powerful.
What a high fecal lactoferrin result can mean
An elevated fecal lactoferrin test result tells you neutrophils are entering the bowel. Several very different conditions produce that pattern, and sorting between them is the work that follows the test.
Inflammatory bowel disease
This is the most common reason for a persistently high result. Both Crohn’s disease and ulcerative colitis involve sustained neutrophil recruitment into the intestinal wall, and levels generally track how active the disease is. In ulcerative colitis, where inflammation is continuous and confined to the colon, the correlation with what an endoscope sees tends to be tighter than in Crohn disease, which can affect isolated segments including parts of the small bowel that shed less material into stool.
Invasive bacterial infection
Organisms that invade the intestinal lining rather than simply irritating it, such as Salmonella, Shigella, Campylobacter, and invasive Escherichia coli, drive lactoferrin sharply upward. This is why an acute presentation usually prompts a stool culture for bacterial pathogens alongside the inflammation marker. Toxin-mediated illness deserves separate attention too, and testing for Clostridioides difficile toxin in stool is standard after recent antibiotics or a hospital stay. Ordinary viral gastroenteritis raises the marker much less, if at all.
Medication-related inflammation
Nonsteroidal anti-inflammatory drugs, including common over-the-counter painkillers, can inflame the small bowel and colon and lift stool inflammation markers in people with no underlying disease. Immune checkpoint inhibitors used in cancer treatment cause a distinctive colitis that behaves similarly on stool testing. Both are important to declare before the sample is taken.
Other structural causes
Diverticular inflammation, radiation damage to the bowel, and some tumors can also raise the marker. Elevated stool inflammation is not a cancer test, but persistent unexplained elevation in an adult over 45, particularly with bleeding or weight loss, is one of the situations where evaluation for colorectal cancer becomes part of the plan.
Fecal lactoferrin, fecal calprotectin, and blood CRP compared
These three markers are often discussed as alternatives, but they answer slightly different questions. The table below sets them side by side.
| Feature | Fecal lactoferrin | Fecal calprotectin | Blood CRP |
|---|---|---|---|
| Source | Neutrophil granules released into the bowel | Neutrophil cytoplasm released into the bowel | Made by the liver in response to circulating signals |
| What it localizes | Inflammation inside the intestine | Inflammation inside the intestine | Inflammation anywhere in the body |
| Sample | Stool | Stool | Blood draw |
| Main strength | Stable in stool, strong negative predictive value for active IBD | Largest evidence base, widely validated cutoffs | Fast, cheap, easy to repeat |
| Main limitation | Fewer standardized cutoffs across assays | Also raised by infection and NSAIDs | Normal in many people with active bowel inflammation |
| Typical role | Ruling out active IBD, monitoring known disease | First-line stool inflammation marker in most health systems | Complementary marker, systemic severity |
In practice the two stool markers behave so similarly that most guidelines treat them as interchangeable options rather than as competitors, and the choice usually comes down to which assay a laboratory has validated and which one a payer covers. Calprotectin has the larger published evidence base and is stocked more widely, so it is the default in many settings; lactoferrin is favored by some laboratories for its stability and by clinicians already following a patient with it.
Blood CRP is not a substitute. A meaningful proportion of people with endoscopically active bowel inflammation have a completely normal CRP, especially when disease is limited to the colon lining. Our explanation of high-sensitivity CRP and silent inflammation covers why a normal systemic marker can coexist with real local disease.
Monitoring known inflammatory bowel disease
The strongest case for a fecal lactoferrin test is not initial diagnosis but follow-up. Once inflammatory bowel disease is confirmed, repeated stool markers let a care team watch the bowel without repeating colonoscopy every few months.
Detecting a flare early
Levels typically rise before symptoms return. A patient in clinical remission whose marker climbs across two consecutive samples is often heading toward a flare, and treatment can be adjusted before the flare fully arrives. Rising markers also prompt a check for other explanations, such as an incidental infection or recent painkiller use.
Judging whether a treatment is working
After starting or switching a biologic or immunosuppressant, a falling marker is early evidence that the drug is reaching the tissue. A marker that stays high despite improving symptoms suggests the underlying inflammation has not been controlled, which changes decisions about dose and timing.
Confirming mucosal healing
Modern treatment targets healing of the intestinal lining, not just the absence of symptoms, because healed tissue predicts fewer hospitalizations and surgeries. Stool markers are the practical way to track that between endoscopies. Persistent normal values over time give reasonable confidence the lining has healed; persistently high values argue for a direct look. Other clues, such as visible mucus or a change in stool consistency, are followed alongside the numbers.
False positives, pitfalls, and sample handling
A raised result is not automatically a disease result. Several ordinary situations lift the marker.
- Nonsteroidal anti-inflammatory drugs taken in the days or weeks before the sample.
- A recent gastrointestinal infection, which can keep markers elevated for several weeks after symptoms settle.
- Bleeding into the gut from any cause, including hemorrhoids or a recent procedure, since blood carries neutrophils with it.
- Breast milk in infants, which is naturally rich in lactoferrin and makes the test unreliable in breastfed babies.
- Poor sample handling: a specimen left warm, delayed in transit, or contaminated with urine or toilet water.
- Very watery stool, which dilutes the sample, and constipation, which concentrates it.
False negatives happen too. Inflammation limited to the upper small bowel may not shed enough protein into stool to register, and disease that is genuinely patchy can be missed on the day you happen to collect. This is one reason a normal result in someone with alarm symptoms never ends the investigation on its own. Menstrual blood and visible bleeding also complicate reading, and any visible blood in stool should be reported to your clinician regardless of what the inflammation marker shows.
What happens next, and when to see a doctor
An abnormal fecal lactoferrin test result is a signal to investigate, not a verdict. The follow-up is usually a combination of the following.
- Blood work, typically a complete blood count and CRP, looking for anemia, a raised white cell count, or systemic inflammation. Low iron stores often accompany chronic gut inflammation.
- A stool infection panel to exclude bacterial and parasitic causes before an inflammatory diagnosis is made.
- Testing for celiac disease when diarrhea, weight loss, or nutrient deficiencies are prominent.
- Screening for bleeding with a fecal occult blood test when bleeding is suspected but not visible.
- Colonoscopy with biopsies, which remains the definitive way to confirm inflammatory bowel disease and to see how far it extends.
- Cross-sectional imaging such as MR enterography when small bowel Crohn disease is suspected.
When to see a doctor
Arrange medical review promptly, whatever a stool marker shows, if you have any of the following.
- Blood in the stool, or black tarry stools.
- Fever with abdominal pain or diarrhea.
- Unintentional weight loss.
- Diarrhea that wakes you at night.
- Diarrhea lasting more than four weeks.
- Severe or worsening abdominal pain, or vomiting that prevents you from keeping fluids down.
- A family history of inflammatory bowel disease or colorectal cancer alongside new bowel symptoms.
Seek urgent care for severe abdominal pain with a rigid abdomen, high fever, or signs of dehydration such as dizziness on standing and passing very little urine.
Latest scientific advances
Research published since 2023 has clarified where this marker fits and where it is heading. Here is what the most relevant work found, in plain language.
Guidelines now place stool markers at the center of ulcerative colitis care
In 2023 the American Gastroenterological Association published a formal guideline on using biomarkers to manage ulcerative colitis. It concluded that stool inflammation markers, including lactoferrin, together with blood CRP, can safely replace routine endoscopy for many follow-up decisions in patients who feel well. What this means for you: if you have ulcerative colitis, a stool test every few months may take the place of some scheduled colonoscopies, and a normal result is treated as meaningful evidence rather than as a formality.
An early stool reading can predict how well a biologic will work
A 2023 reanalysis of two large drug trials looked at more than a thousand patients with ulcerative colitis and measured lactoferrin just four weeks after starting a biologic medicine. Patients whose level had already dropped were considerably more likely to be in remission at the end of the treatment course, and less likely to need surgery to remove the colon over the following years. What this means for you: an early stool test after starting a new drug can give your team a useful preview of whether it is working, months before an endoscopy would. This was a post-hoc analysis, meaning the question was asked after the trials ended rather than planned from the start, so it points a direction rather than settling the matter.
The marker tracks what the endoscope sees in children
A 2025 Japanese study of children with early-onset inflammatory bowel disease compared stool markers against endoscopy findings and found that both lactoferrin and calprotectin corresponded closely to the degree of visible inflammation. What this means for you: in pediatric care, where avoiding sedation and repeated procedures matters a great deal, stool testing is a credible way to follow disease activity. The study was retrospective, meaning it reviewed records already collected, so it shows a strong association rather than proving the test can replace endoscopy.
Stool markers help with colitis caused by cancer immunotherapy
A 2025 study followed patients who developed bowel inflammation as a side effect of immune checkpoint inhibitors, a class of cancer drug that removes the brakes on the immune system. Stool inflammation markers reflected how severe the colitis looked at colonoscopy. What this means for you: if you are on immunotherapy and develop diarrhea, a stool test may help your oncology team judge severity without an invasive procedure during cancer treatment. The group studied was small, so the finding needs confirmation in larger numbers.
Point-of-care devices are being developed
A 2026 review surveyed biosensors designed to measure lactoferrin and calprotectin quickly and outside a central laboratory, the way a glucose meter works for blood sugar. What this means for you: home or clinic-side stool testing is a realistic direction for the next several years, which would make frequent monitoring far easier. These devices are still largely experimental and are not yet standard care.
Glossary
| Term | Definition |
|---|---|
| Lactoferrin | An iron-binding protein carried by neutrophils and also found in breast milk, tears, and saliva. In stool it signals that white blood cells have entered the bowel. |
| Neutrophil | The most common type of white blood cell and the first to arrive at inflamed or infected tissue. |
| Immunoassay | A laboratory method that uses antibodies to detect and measure a specific protein in a sample. |
| Calprotectin | Another neutrophil protein measured in stool for the same purpose as lactoferrin. It has the widest clinical use of the stool inflammation markers. |
| CRP | C-reactive protein, a blood marker made by the liver that rises with inflammation anywhere in the body. |
| Inflammatory bowel disease | A group of chronic conditions, mainly Crohn disease and ulcerative colitis, in which the immune system inflames and damages the intestine. |
| Mucosal healing | Repair of the intestinal lining seen at endoscopy. It is a treatment target because it predicts fewer complications than symptom relief alone. |
| Endoscopy | A procedure using a flexible camera to look directly at the lining of the digestive tract and take tissue samples. |
| Negative predictive value | How reliably a normal result rules a condition out. A high value means a normal test result is strongly reassuring. |
| Post-hoc analysis | A study that asks a new question of data already collected for a different purpose. It generates leads rather than final answers. |
FAQ
What is a normal fecal lactoferrin level?
There is no single universal number, because different assays use different units and cutoffs. Many laboratories report values under roughly 7 micrograms per gram of stool as normal, with results above that flagged for follow-up, while other laboratories report only a positive or negative result. Always compare your value with the reference range printed on your own report. A normal result in someone without alarm symptoms substantially lowers the likelihood of active inflammatory bowel disease, but it does not rule out every gut condition, and it says nothing about digestion, food intolerance, or motility problems.
Can this test tell inflammatory bowel disease apart from IBS?
It helps considerably, though it is not a standalone answer. Irritable bowel syndrome does not damage the intestinal lining, so stool inflammation markers are typically normal in people who have it, while active Crohn disease or ulcerative colitis usually pushes them well above the cutoff. That contrast is why the test is often used as a filter before deciding who needs a colonoscopy. Overlap exists in both directions: mild or patchy inflammation can produce a normal result, and infections or painkillers can raise the marker in someone whose underlying problem is functional. Your clinician interprets it alongside symptoms and other tests.
How does lactoferrin compare with calprotectin?
Both come from neutrophils that have entered the bowel, both are measured in stool, and both perform similarly at separating inflammatory from functional bowel disease. Calprotectin has been studied more extensively and has more widely agreed cutoffs, so it is the more common first choice and is more likely to be covered by insurance. Lactoferrin is notably stable in stool, which makes sample transport more forgiving, and some laboratories prefer it for that reason. If you are already being followed with one of them, staying with the same marker and the same laboratory makes the trend easier to read.
Can breastfeeding or an infection raise the result?
Yes to both. Breast milk is naturally rich in lactoferrin, so results in breastfed infants are unreliable and this test is generally avoided in that group. Bacterial infections that invade the intestinal lining, such as Salmonella, Shigella, and Campylobacter, raise the marker sharply, and levels can stay elevated for several weeks after an infection has cleared. Nonsteroidal anti-inflammatory painkillers, recent bowel bleeding, and recent endoscopic procedures can all lift the number as well. Tell your clinician about any recent illness, travel, antibiotics, or regular painkiller use before the sample is collected.
How is the sample collected?
You are given a small container and asked to collect a stool sample at home, usually with no dietary restriction or preparation beforehand. Catch the sample before it touches toilet water, avoid contamination with urine, and use the scoop provided to transfer a small amount into the container. Seal it, label it, refrigerate it if you cannot deliver it immediately, and return it to the laboratory as quickly as the instructions specify. Heat and delay degrade the protein and can produce a falsely low reading. If you are menstruating or have visible bleeding, ask whether to postpone.
How often should the test be repeated?
That depends on why it was ordered. For a first evaluation of unexplained diarrhea, one result is often enough to guide the next step, with a repeat in two to four weeks if the value sits near the cutoff. For someone with established inflammatory bowel disease in remission, testing every three to six months is a common pattern, with extra samples after a treatment change or when symptoms shift. After starting a new medication, an early test at around four to twelve weeks can show whether inflammation is responding. Your gastroenterology team sets the interval.
Sources
- MedlinePlus, National Library of Medicine — Calprotectin Stool Test — MedlinePlus Medical Test, updated 2024 — medlineplus.gov
- National Institute of Diabetes and Digestive and Kidney Diseases — Diagnosis of Crohn’s Disease — NIDDK, National Institutes of Health — niddk.nih.gov
- Mayo Clinic — Inflammatory Bowel Disease: Diagnosis and Treatment — Mayo Clinic Patient Care and Health Information — mayoclinic.org
- Singh S, Ananthakrishnan AN, Nguyen NH, et al. — AGA Clinical Practice Guideline on the Role of Biomarkers for the Management of Ulcerative Colitis — Gastroenterology, 2023 — doi.org/10.1053/j.gastro.2022.12.007
- Chen R, Tie Y, Zhang X, et al. — Fecal Lactoferrin Early Predicts Long-Term Outcomes in Ulcerative Colitis: A Post-Hoc Analysis of the UNIFI and PURSUIT Trials — United European Gastroenterology Journal, 2023 — doi.org/10.1002/ueg2.12431
- Yoshimura R, Kudo T, Toda M, et al. — Fecal Surrogate Markers Strongly Correlate with Endoscopic Findings in Pediatric Onset Inflammatory Bowel Disease: A Retrospective Study in Japan — Intestinal Research, 2025 — doi.org/10.5217/ir.2025.00103
- Morikawa R, Fujii T, Tamura A, et al. — Diagnostic Performance of Fecal Biomarkers and Their Correlation with Endoscopic Severity in Immune Checkpoint Inhibitor-Related Colitis — Digestion, 2025 — doi.org/10.1159/000549888
- Sitkov N, Ryabko A, Ivanov S, et al. — Biosensor-Based Detection of Calprotectin and Lactoferrin as Neutrophil-Derived Markers of Inflammatory Bowel Diseases: From Molecular Pathophysiology to Point-of-Care Platforms — International Journal of Molecular Sciences, 2026 — doi.org/10.3390/ijms27062692
Further reading
- Compare the most widely used stool inflammation marker by reading our fecal calprotectin results guide.
- Explore the condition most often confirmed after a raised stool marker in our Crohn’s disease overview.
- Understand the other main form of inflammatory bowel disease with our ulcerative colitis guide.
- Recognize the symptom pattern that a normal result supports by reading our irritable bowel syndrome guide.
- Investigate hidden gastrointestinal bleeding with our fecal occult blood test results guide.
Understand your lab results with BloodSense
A stool inflammation marker rarely arrives alone. It usually sits on a report next to calprotectin, a complete blood count, CRP, ferritin, and sometimes a stool infection panel, and the meaning comes from how those values fit together. BloodSense reads your results in context and explains, in plain language, what each value suggests and which questions are worth raising at your next appointment. It helps you understand your report; it does not diagnose and it does not replace your doctor.
